CIAO DATE: 11/2009
October 2009
Access to medicines poses a critical challenge in developing countries: prices are high, and new or adapted medicines and vaccines to address diseases of the developing world are lacking. This presents a major barrier to achieving the right to health in developing countries. More than five million people in low and middle income countries still lack access to anti-retroviral medicines to treat HIV and AIDS, and non-communicable diseases have unleashed a new epidemic of suffering across the developing world.
Resource link: Trading Away Access to Medicines: How the European Union's trade agenda has taken a wrong turn [PDF] - 619K